Short answer · Medically reviewed summary · Last updated: 2026-04-08
Pleurisy is not considered a rare disease, but rather a common clinical manifestation of underlying conditions, meaning global prevalence statistics are difficult to track precisely. While exact incidence rates are not centrally registered, it is estimated that millions of people experience pleurisy annually as a secondary complication of infections, inflammatory diseases, or trauma. Is Pleurisy considered a rare disease? Unlike many conditions mapped on DiseaseMaps.org, pleurisy is not classified as a rare or ultra-rare disease.
Pleurisy is not considered a rare disease, but rather a common clinical manifestation of underlying conditions, meaning global prevalence statistics are difficult to track precisely. While exact incidence rates are not centrally registered, it is estimated that millions of people experience pleurisy annually as a secondary complication of infections, inflammatory diseases, or trauma.
Unlike many conditions mapped on DiseaseMaps.org, pleurisy is not classified as a rare or ultra-rare disease. It is a condition defined by the inflammation of the pleura—the membrane surrounding the lungs—and is typically a symptom of another medical issue rather than a primary, stand-alone diagnosis. Because it is a secondary condition, medical registries often track the underlying cause (such as pneumonia or pulmonary embolism) rather than the pleurisy itself, making it challenging to establish an exact global prevalence.
The incidence of pleurisy varies significantly based on the prevalence of its underlying causes within a specific population. Data suggests that it affects both males and females, though some underlying etiologies—such as certain autoimmune conditions that cause pleurisy—may show a higher prevalence in females. Regarding age of onset, pleurisy can occur at any stage of life, from childhood through old age, though it is most frequently diagnosed in adults due to the higher incidence of age-related respiratory infections and inflammatory conditions.
Accurate epidemiological data for pleurisy is hindered by several systemic challenges in clinical reporting:
At DiseaseMaps.org, we recognize that while medical literature focuses on large-scale statistics, the lived experience of our community provides vital context. Currently, 3 people with pleurisy have joined our platform to share their journeys. For these individuals, the condition is far from a simple medical statistic; it is a daily reality involving chronic pain management and the search for underlying triggers. Real-world patient data helps us understand the impact of pleurisy on quality of life, which is often under-represented in traditional clinical research.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.